查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1908602

过敏诊断和治疗市场规模、份额和趋势分析报告：按类型、过敏原类型、检测类型、地区和细分市场预测（2026-2033 年）

Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics, Therapeutics), By Allergen Type (Food, Inhaled, Drug), By Test Type (In Vivo Tests, In Vitro Tests), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

过敏诊断和治疗市场概览

全球过敏诊断和治疗市场预计到 2025 年价值 371 亿美元，预计到 2033 年将达到 780 亿美元。

预计从 2026 年到 2033 年，该市场将以 9.95% 的复合年增长率成长。市场的主要驱动因素包括过敏症盛行率上升、技术进步、新产品推出以及免疫疗法药物的高普及率。

根据美国食品药物管理局（FDA）的数据，美国最常见的食物过敏包括对牛奶、鸡蛋、鱼类、贝类、坚果、花生、小麦、大豆和芝麻的过敏。美国疾病管制与预防中心（CDC）报告称，美国有10%的患者自述对青霉素过敏，但只有不到1%的患者会出现真正的过敏反应。生活方式的改变和污染的加剧是导致过敏性疾病发生率上升的主要因素。预计在预测期内，治疗手段先进的药物，特别是免疫疗法，将满足患者未被满足的需求，从而推动市场成长。例如，2024年2月，美国食品药物管理局（FDA）批准了儿童 （奥马珠单抗）注射剂，这是一种免疫球蛋白E（IgE）介导的食物过敏治疗药物，用于减少接触多种食物后可能核准的I型过敏反应，包括降低某些1岁及以上成人和儿童发生过敏性休克的风险。 Zolaia旨在重复给药以降低过敏反应的风险，但未核准用于即时治疗过敏反应，包括过敏性休克。

过敏性疾病盛行率的上升是推动预测期内过敏治疗市场成长的关键因素之一。慢性呼吸系统疾病的主要风险因素包括室内外空气污染暴露增加以及职业暴露。由于工业活动和都市化导致环境污染物暴露增加，都市区的过敏性疾病盛行率远高于农村地区。根据世界卫生组织（世卫组织）2024年1月发布的数据，美国约有四分之一的婴儿和三分之一的成年人患有季节性过敏。此外，美国约有6%的婴儿和成年人患有食物过敏，其中黑人、亚裔和西班牙裔族群的盛行率最高。

预计在预测期内，对体外诊断试剂（IVD）的需求不断增长将推动市场发展。体外血液检测用于诊断食物、吸入物、皮肤和药物过敏。这些检测具有微创、经济高效、操作简便等诸多优势，预计将推动该市场实现盈利成长。此外，低成本、高效的过敏检测体外诊断试剂的开发、检查室自动化程度的提高以及试剂租赁协议数量的增加，预计也将促进未来几年市场的扩张。

此外，体外诊断（IVD）过敏测试研发资金的增加正在推动市场强劲成长。例如，2024年10月，Allergios公司获得了荷兰健康基金会（HealthHolland）的津贴，进一步加强了其与瓦赫宁根大学及研究所的公私合营。该公司致力于检验其尖端的食物过敏诊断工具—GranulEye测试。在Janneke Ruynemans-Kuurtz博士的主导，该研究结合了临床和分析方法，检验GranulEye对花生过敏的有效性。研究人员将该测试的嗜碱性粒细胞活化视觉化方法与现有的嗜碱性粒细胞活化测试进行了比较。与皮肤点刺试验、IgE测试以及双盲安慰剂对照食物激发试验不同，GranulEye旨在可靠地诊断真正的临床过敏，而不仅仅是致敏反应。

目录

第一章调查方法和范围

第二章执行摘要

3. 过敏诊断和治疗市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 过敏性疾病呈上升趋势
    • 技术进步和新产品发布
    • 免疫疗法药物的高采用率
  • 市场限制因素分析
    • 由于技术成本高昂，发展中国家的技术普及率和渗透率较低。
    • 过敏原标准化程度不足
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 过敏诊断与治疗市场：类型与方法、估算与趋势分析

  • 过敏诊断与治疗市场：按类型分類的差异分析
  • 诊断
    • 装置
    • 消耗品
    • 服务
  • 治疗方法
    • 抗组织胺药物
    • 减充血剂
    • 皮质类固醇
    • 肥大细胞稳定剂
    • 白三烯抑制剂
    • 鼻用抗胆碱能药物
    • 免疫调节剂
    • 肾上腺素
    • 免疫疗法

第五章 过敏诊断与治疗市场：依过敏原类型分類的估算与趋势分析

  • 过敏诊断与治疗市场：按过敏原类型分類的波动分析
  • 食物
    • 乳製品
    • 鸡肉製品
    • 坚果
    • 花生
    • 甲壳类动物
    • 小麦
    • 大豆
  • 其他食物过敏原
  • 可吸入性
  • 製药
  • 其他过敏原类型

第六章 过敏诊断和治疗市场：按检测类型分類的估算和趋势分析

  • 过敏诊断与治疗市场：依检测类型分析波动状况
  • 体内试验
    • 皮肤点刺试验
    • 皮内试验
    • 斑贴测试
  • 体外试验

7. 过敏诊断与治疗市场：区域业务分析

  • 区域市场概览
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 公司热力图分析
  • 公司简介
    • R-Biopharm AG
    • EUROIMMUN Medizinische Labordiagnostika AG
    • DASIT Group SPA
    • AESKU.GROUP GmbH
    • bioMerieux
    • Danaher
    • Thermo Fisher Scientific, Inc
    • Stallergenes Greer
    • Minaris Medical America, Inc.
    • Siemens Healthcare GmbH
    • Omega Diagnostics Group PLC
    • HYCOR Biomedical
    • Lincoln Diagnostics, Inc.
    • Alcon
    • HOB BIoTech Group Corp., Ltd.
    • AbbVie Inc.
    • Allergy Therapeutics
    • Sanofi
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • GSK plc
    • F. Hoffmann-La Roche Ltd.
    • Merck & Co., Inc.
    • Astellas Pharma Inc.
    • Epigenomics AG
Product Code: 978-1-68038-701-8

Allergy Diagnostics And Therapeutics Market Summary

The global allergy diagnostics and therapeutics market size was estimated at USD 37.10 billion in 2025 and is expected to reach USD 78.00 billion by 2033, projected to grow at a CAGR of 9.95% from 2026 to 2033. Some of the major factors driving the market are the rising prevalence of allergies, advancements in technology, the launch of new products, and the high adoption of immunotherapy drugs.

According to the FDA, the most common food allergies in the U.S. include milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame. The CDC reported that 10% of patients in the U.S. claim to be allergic to penicillin; less than 1% are truly allergic. Changing lifestyle and growing pollution are some of the key factors contributing to the increasing incidence of allergic conditions. The introduction of therapeutically advanced drugs, namely immunotherapy, which solves unmet patient needs, is expected to boost market growth over the forecast period. For instance, in February 2024, the U.S. Food and Drug Administration approved Xolair (omalizumab) injection for immunoglobulin E-mediated food allergy in certain adults and children 1 year or older for the reduction of allergic reactions (Type I), including reducing the risk of anaphylaxis, that may occur with accidental exposure due to more than one food. In addition, Xolair is intended for repeated use to reduce the risk of allergic reactions and is not approved for the immediate emergency treatment of allergic reactions, including anaphylaxis.

The rising prevalence of allergies is one of the important reasons driving the growth of the allergy therapeutics market over the predicted period. High risk factors for chronic respiratory disorders include increased exposure to outdoor and indoor air pollution, as well as occupational exposure. Allergies are far more common in cities than in rural areas, owing to increased exposure to environmental contaminants as a result of industrial activity and urbanization. According to statistics published by the WHO in January 2024, around 1 in 4 children and 1 in 3 adults have a seasonal allergy in the U.S. Nearly 6% of children and adults in the U.S. suffer from a food allergy, with the rate being highest among black, Asian, and Hispanic individuals.

Increasing demand for IVD testing is likely to drive the market over the forecast period. In vitro blood tests are used to diagnose food, inhalation, skin, and medication allergies. These tests have several advantages, including the fact that they are minimally invasive, cost-effective, and user-friendly, which is expected to provide profitable growth prospects in this market. Furthermore, the development of low-cost and effective in vitro diagnostic tests for allergy detection, increased lab automation, and an increase in reagent rental agreements are all projected to contribute to market expansion in the future years.

In addition, rising funding for the development of IVD allergy tests is driving strong market growth. For instance, in October 2024, Allergios received a HealthHolland grant to strengthen a public-private partnership with Wageningen University & Research focused on verifying the GranulEye test, a cutting-edge food allergy diagnosis tool. The study, conducted by Dr. Janneke Ruinemans-Koerts, used both clinical and analytical methods to validate GranulEye for peanut allergy, comparing its basophil-activation visualization method to existing basophil activation tests. Unlike skin-prick tests, IgE tests, or the difficult double-blind placebo-controlled food challenge, GranulEye aims to diagnose actual clinical allergy rather than mere sensitization reliably.

Global Allergy Diagnostics And Therapeutics Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global allergy diagnostics and therapeutics market report based on type, allergen type, test type, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostics
    • Instruments
    • Consumables
    • Services
  • Therapeutics
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-cholinergic
    • Immuno-modulators
    • Epinephrine
    • Immunotherapy
  • Allergen Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Food
    • Dairy Products
    • Poultry Product
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soy
    • Other Food Allergens
  • Inhaled
  • Drug
  • Other allergen types
  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • In Vivo Tests
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In Vitro Tests
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Type Method
      • 1.1.1.2. Allergen Type Segment
      • 1.1.1.3. Test Type Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type Snapshot
  • 2.3. Allergen Type Snapshot
  • 2.4. Type Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Allergy Diagnostics and Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising incidence of allergies
    • 3.4.2. Advancements in technology and the launch of new products
    • 3.4.3. High adoption of immunotherapy drugs
  • 3.5. Market Restraint Analysis
    • 3.5.1. Low adoption and penetration in developing countries due to the high cost of technology
    • 3.5.2. Lack of allergen standardization
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Allergy Diagnostics and Therapeutics Market: Type Method Estimates & Trend Analysis

  • 4.1. Allergy Diagnostics and Therapeutics Market: Test Method Movement Analysis
  • 4.2. Diagnostics
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.2. Instruments
      • 4.2.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.3. Consumables
      • 4.2.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.2.4. Services
      • 4.2.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Therapeutics
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Antihistamines
      • 4.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Decongestants
      • 4.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Corticosteroids
      • 4.3.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Mast Cell Stabilizers
      • 4.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.6. Leukotriene Inhibitors
      • 4.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.7. Nasal Anti-cholinergic
      • 4.3.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.8. Immuno-modulators
      • 4.3.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.9. Epinephrine
      • 4.3.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.10. Immunotherapy
      • 4.3.10.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Allergy Diagnostics and Therapeutics Market: Allergen Type Estimates & Trend Analysis

  • 5.1. Allergy Diagnostics and Therapeutics Market: Mode Movement Analysis
  • 5.2. Food
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.2. Dairy Products
      • 5.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.3. Poultry Product
      • 5.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.4. Tree Nuts
      • 5.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.5. Peanuts
      • 5.2.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.6. Shellfish
      • 5.2.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.7. Wheat
      • 5.2.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.2.8. Soy
      • 5.2.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Other Food Allergens
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Inhaled
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Drug
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Other allergen types
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Allergy Diagnostics and Therapeutics Market: Test Type Estimates & Trend Analysis

  • 6.1. Allergy Diagnostics and Therapeutics Market: Type Movement Analysis
  • 6.2. In Vivo tests
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2. Skin Prick Test
      • 6.2.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3. Intradermal Test
      • 6.2.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4. Patch Test
      • 6.2.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. In Vitro tests
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Allergy Diagnostics and Therapeutics Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Allergy Diagnostics and Therapeutics Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. U.S. Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Canada Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Competitive Scenario
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Mexico Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. UK Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Germany Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.4. Spain
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Spain Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. France Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Italy Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Denmark Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Sweden Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Norway Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Japan Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. China Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. India Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. South Korea Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Thailand Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Australia Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Brazil Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Argentina Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. South Africa Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Saudi Arabia Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. UAE Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Kuwait Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. R-Biopharm AG
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. EUROIMMUN Medizinische Labordiagnostika AG
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. DASIT Group SPA
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. AESKU.GROUP GmbH
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. bioMerieux
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Danaher
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Thermo Fisher Scientific, Inc
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Stallergenes Greer
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Minaris Medical America, Inc.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Siemens Healthcare GmbH
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Omega Diagnostics Group PLC
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives
    • 8.4.12. HYCOR Biomedical
      • 8.4.12.1. Company Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Strategic Initiatives
    • 8.4.13. Lincoln Diagnostics, Inc.
      • 8.4.13.1. Company Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Strategic Initiatives
    • 8.4.14. Alcon
      • 8.4.14.1. Company Overview
      • 8.4.14.2. Financial Performance
      • 8.4.14.3. Product Benchmarking
      • 8.4.14.4. Strategic Initiatives
    • 8.4.15. HOB Biotech Group Corp., Ltd.
      • 8.4.15.1. Company Overview
      • 8.4.15.2. Financial Performance
      • 8.4.15.3. Product Benchmarking
      • 8.4.15.4. Strategic Initiatives
    • 8.4.16. AbbVie Inc.
      • 8.4.16.1. Company Overview
      • 8.4.16.2. Financial Performance
      • 8.4.16.3. Product Benchmarking
      • 8.4.16.4. Strategic Initiatives
    • 8.4.17. Allergy Therapeutics
      • 8.4.17.1. Company Overview
      • 8.4.17.2. Financial Performance
      • 8.4.17.3. Product Benchmarking
      • 8.4.17.4. Strategic Initiatives
    • 8.4.18. Sanofi
      • 8.4.18.1. Company Overview
      • 8.4.18.2. Financial Performance
      • 8.4.18.3. Product Benchmarking
      • 8.4.18.4. Strategic Initiatives
    • 8.4.19. Pfizer Inc.
      • 8.4.19.1. Company Overview
      • 8.4.19.2. Financial Performance
      • 8.4.19.3. Product Benchmarking
      • 8.4.19.4. Strategic Initiatives
    • 8.4.20. Teva Pharmaceutical Industries Ltd.
      • 8.4.20.1. Company Overview
      • 8.4.20.2. Financial Performance
      • 8.4.20.3. Product Benchmarking
      • 8.4.20.4. Strategic Initiatives
    • 8.4.21. Sun Pharmaceutical Industries Ltd.
      • 8.4.21.1. Company Overview
      • 8.4.21.2. Financial Performance
      • 8.4.21.3. Product Benchmarking
      • 8.4.21.4. Strategic Initiatives
    • 8.4.22. GSK plc
      • 8.4.22.1. Company Overview
      • 8.4.22.2. Financial Performance
      • 8.4.22.3. Product Benchmarking
      • 8.4.22.4. Strategic Initiatives
    • 8.4.23. F. Hoffmann-La Roche Ltd.
      • 8.4.23.1. Company Overview
      • 8.4.23.2. Financial Performance
      • 8.4.23.3. Product Benchmarking
      • 8.4.23.4. Strategic Initiatives
    • 8.4.24. Merck & Co., Inc.
      • 8.4.24.1. Company Overview
      • 8.4.24.2. Financial Performance
      • 8.4.24.3. Product Benchmarking
      • 8.4.24.4. Strategic Initiatives
    • 8.4.25. Astellas Pharma Inc.
      • 8.4.25.1. Company Overview
      • 8.4.25.2. Financial Performance
      • 8.4.25.3. Product Benchmarking
      • 8.4.25.4. Strategic Initiatives
    • 8.4.26. Epigenomics AG
      • 8.4.26.1. Company Overview
      • 8.4.26.2. Financial Performance
      • 8.4.26.3. Product Benchmarking
      • 8.4.26.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Global Allergy Diagnostics and Therapeutics Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 5 Global Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 6 Global Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 7 North America Allergy Diagnostics and Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • Table 8 North America Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 9 North America Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 10 North America Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 11 U.S. Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 U.S. Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 13 U.S. Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 14 Canada Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 Canada Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 16 Canada Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 17 Mexico Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 18 Mexico Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 19 Mexico Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 20 Europe Allergy Diagnostics and Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 22 Europe Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 23 Europe Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 24 UK Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 25 UK Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 26 UK Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 27 Germany Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Germany Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 29 Germany Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 30 France Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 31 France Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 32 France Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 33 Italy Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 34 Italy Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 35 Italy Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 36 Spain Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 37 Spain Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 38 Spain Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 39 Denmark Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 Denmark Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 41 Denmark Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 42 Sweden Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 43 Sweden Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 44 Sweden Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 45 Norway Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 46 Norway Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 47 Norway Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Allergy Diagnostics and Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 52 Japan Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 53 Japan Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 54 Japan Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 55 China Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 China Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 57 China Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 58 India Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 59 India Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 60 India Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 61 Australia Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 62 Australia Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 63 Australia Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 64 South Korea Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 South Korea Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 66 South Korea Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 67 Thailand Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 68 Thailand Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 69 Thailand Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 70 Latin America Allergy Diagnostics and Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 72 Latin America Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 73 Latin America Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 74 Brazil Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 75 Brazil Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 76 Brazil Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 77 Argentina Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 78 Argentina Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 79 MEA Allergy Diagnostics and Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • Table 80 MEA Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 81 MEA Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 82 MEA Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 83 South Africa Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 84 South Africa Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 85 South Africa Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 89 UAE Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 90 UAE Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 91 UAE Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Allergy Diagnostics and Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Allergy Diagnostics and Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Allergy Diagnostics and Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Allergy Diagnostics and Therapeutics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment.
  • Fig. 8 Market formulation & validation
  • Fig. 9 Allergy Diagnostics and Therapeutics Market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook.
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Allergy Diagnostics and Therapeutics Market driver impact
  • Fig. 14 Allergy Diagnostics and Therapeutics Market restraint impact
  • Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 Allergy Diagnostics and Therapeutics Market: Type outlook and key takeaways
  • Fig. 19 Allergy Diagnostics and Therapeutics Market: Type movement analysis & market share 2025 & 2033
  • Fig. 20 Diagnostics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Consumable market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Services market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Antihistamines Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Decongestants Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Corticosteroids Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Mast Cell Stabilizers Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Leukotriene Inhibitors Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Nasal Anti-cholinergic Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Immuno-modulators Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Epinephrine Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Immunotherapy Allergy Diagnostics and Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Allergy Diagnostics and Therapeutics Market: Allergen Type outlook and key takeaways
  • Fig. 35 Allergy Diagnostics and Therapeutics Market: Allergen Type movement analysis & market share 2025 & 2033
  • Fig. 36 Food market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Dairy Products market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Poultry Product market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Tree Nuts market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Peanuts market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Shellfish market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Wheat market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Soy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Other Food Allergens market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Inhaled market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Drug market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Allergy Diagnostics and Therapeutics Market: Test Type outlook and key takeaways
  • Fig. 49 Allergy Diagnostics and Therapeutics Market: Test Type movement analysis & market share 2025 & 2033
  • Fig. 50 In vivo Test market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Skin Prick Test market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Intradermal Test market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Patch Test market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 In Vitro Test market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Regional marketplace: Key takeaways
  • Fig. 56 Global Allergy Diagnostics and Therapeutics Market: Regional movement analysis
  • Fig. 57 U.S. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Europe market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 61 UK market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Germany market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 63 France market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Italy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Spain market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Sweden market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Norway market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 69 Asia Pacific market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Japan market estimates and forecast, 2021 - 2033(USD Million)
  • Fig. 71 China market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 India market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 73 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Australia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Thailand market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Latin America market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 77 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 MEA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 81 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 82 UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 83 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 84 Strategy framework